Assesment the clinical effect of myoinositol on insulin resistence in women with PCOS

Phase 2

• Conditions: Polycystic Ovarian Syndrome.; Ovarian dysfunction, unspecified

• Registration Number: IRCT2015010319426N4
• Lead Sponsor: Vice chancellor for research, Shahid Beheshti University of Medical Science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 50

Inclusion Criteria

women who were between 20 and 40 years old, and had PCOS diagnosed by a gynecologist.
Exclusion criteria: patients who were diagnosed with Cushing syndrome, congenital adrenal hyperplasia, hyperprolactinemia, hypothyroidism, hyperthyroidism, androgen secreting tumor; medications known to affect metabolic parameters, such as metformin and corticosteroids.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fasting glucose. Timepoint: Before intervention and three months after treatment. Method of measurement: Blood serum.;Fasting insulin. Timepoint: Before intervention and three months after treatment. Method of measurement: Blood serum.;HOMA IR. Timepoint: Before intervention and three months after treatment. Method of measurement: Calculation by formola.

Secondary Outcome Measures

Name	Time	Method
Weight. Timepoint: Before intervention and three months after treatment. Method of measurement: Balance.;Height. Timepoint: Before intervention and three months after treatment. Method of measurement: Meter.;Body Mass Index. Timepoint: Before intervention and three months after treatment. Method of measurement: Formola.;Low density lipoprotein. Timepoint: Before intervention and three months after treatment. Method of measurement: Blood serum.;High density lipoprotein. Timepoint: Before intervention and two months after vitamin D injection. Method of measurement: Blood serum.;Free testosterone. Timepoint: Before intervention and two months after vitamin D injection. Method of measurement: Blood serum.;Dehydoepiandrasteione. Timepoint: Before intervention and two months after vitamin D injection. Method of measurement: Blood serum.;Triglyceride. Timepoint: Before intervention and two months after vitamin D injection. Method of measurement: Blood serum.